Hefei
003020.SZHefei Lifeon Pharmaceutical Co., Ltd. Price (003020.SZ)
Stock Price
Market Cap
Fetching Data...
Enterprise Value
Fetching Data...
Volume
Fetching Data...
Shares Outstanding
191,559,808
(22.3543)%Income Statement Summary
| Revenue | |
| Cost of Revenue | |
| Gross Profit | |
| Operating Expenses | |
| Operating Income | |
| Other Expenses | |
| Net Income |
Income Statement
Hefei Lifeon Pharmaceutical Co., Ltd.Currency: CNY
| YEAR | 2012 | 2013 | 2014 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||||||||||
| Revenue |
733.32M
+0% |
877.72M
+20% |
962.17M
+10% |
1.03B
+7% |
1.17B
+13% |
1.42B
+22% |
1.65B
+16% |
1.89B
+15% |
2.27B
+20% |
2.58B
+13% |
1.90B
-26% |
||||||||
| Cost of Revenue | |||||||||||||||||||
| Cost of Revenue | 598.25M | 709.42M | 786.35M | 839.69M | 908.95M | 998.93M | 1.13B | 1.26B | 1.37B | 1.62B | 922.20M | ||||||||
| Gross Profit | |||||||||||||||||||
| Gross Profit |
135.07M
+0% |
168.30M
+25% |
175.82M
+4% |
188.48M
+7% |
257.62M
+37% |
425.65M
+65% |
517.23M
+22% |
633.64M
+23% |
907.17M
+43% |
964.28M
+6% |
978.59M
+1% |
||||||||
| Gross Profit Ratio | (0.18%) | (0.19%) | (0.18%) | (0.18%) | (0.22%) | (0.30%) | (0.31%) | (0.33%) | (0.40%) | (0.37%) | (0.51%) | ||||||||
| Operating Expenses | |||||||||||||||||||
| Research and Development | 6.71M | 9.10M | 9.19M | 11.80M | 18.39M | 23.79M | 37.44M | 43.31M | 65.86M | 73.80M | 79.91M | ||||||||
| General and Administrative | 17.53M | 21.24M | 23.50M | 22.44M | 6.15M | 16.12M | 8.64M | 14.12M | 11.02M | 15.60M | 21.91M | ||||||||
| Selling, General & Admin... | 84.80M | 108.37M | 109.16M | 93.83M | 125.15M | 274.99M | 336.70M | 407.92M | 616.27M | 631.98M | 651.01M | ||||||||
| Selling & Marketing Exp... | 67.26M | 87.13M | 85.67M | 71.39M | 119.00M | 258.87M | 328.06M | 393.81M | 605.24M | 616.39M | 534.56M | ||||||||
| Depreciation and Amortiz... | 10.45M | 11.29M | 11.07M | 13.04M | 13.60M | 14.13M | 15.17M | 16.16M | 38.49M | 38.21M | 47.34M | ||||||||
| Other Expenses | 2.51M | 4.30M | 5.77M | 6.03M | 1.52M | 153.36k | 23.99M | 26.79M | 42.46M | 47.67M | -7,603,744.00 | ||||||||
| Total Operating Expenses | 87.77M | 111.85M | 112.76M | 110.47M | 164.15M | 318.34M | 398.14M | 478.03M | 724.59M | 753.46M | 723.32M | ||||||||
| Cost and Exponses | 686.02M | 821.27M | 899.11M | 950.16M | 1.07B | 1.32B | 1.53B | 1.74B | 2.09B | 2.37B | 1.65B | ||||||||
| Operating Income | |||||||||||||||||||
| Operating Income |
37.93M
+0% |
50.26M
+32% |
58.34M
+16% |
75.14M
+29% |
89.96M
+20% |
108.27M
+20% |
118.84M
+10% |
157.44M
+32% |
192.45M
+22% |
240.05M
+25% |
255.27M
+6% |
||||||||
| Operating Income Ratio | (0.05%) | (0.06%) | (0.06%) | (0.07%) | (0.08%) | (0.08%) | (0.07%) | (0.08%) | (0.08%) | (0.09%) | (0.13%) | ||||||||
| Other Income and Exp... | |||||||||||||||||||
| Interest Income | 0.00 | 0.00 | 0.00 | 219.56k | 735.48k | 1.18M | 2.43M | 4.30M | 3.35M | 4.39M | 4.65M | ||||||||
| Interest Expenses | 0.00 | 0.00 | 0.00 | 2.54M | 3.13M | 2.60M | 1.14M | 244.64k | 1.36M | 890.23k | 1.40M | ||||||||
| Total Other Income/Exp... | 2.01M | 4.27M | 5.50M | 6.03M | 1.52M | 153.36k | 2.78M | -497,600.00 | 5.68M | -231,601.00 | 2.15M | ||||||||
| EBITDA | |||||||||||||||||||
| EBITDA | 57.75M | 67.74M | 74.12M | 91.04M | 108.40M | 125.42M | 138.26M | 173.62M | 238.19M | 283.29M | 305.10M | ||||||||
| EBITDA ratio | (0.09%) | (0.08%) | (0.08%) | (0.09%) | (0.09%) | (0.09%) | (0.08%) | (0.09%) | (0.10%) | (0.11%) | (0.16%) | ||||||||
| Income Before Tax | |||||||||||||||||||
| Income Before Tax | 39.94M | 54.53M | 63.84M | 81.17M | 91.47M | 108.43M | 121.62M | 156.94M | 194.84M | 239.82M | 257.42M | ||||||||
| Income Before Tax Ratio | (0.05%) | (0.06%) | (0.07%) | (0.08%) | (0.08%) | (0.08%) | (0.07%) | (0.08%) | (0.09%) | (0.09%) | (0.14%) | ||||||||
| Income Tax Expense | |||||||||||||||||||
| Income Tax Expense | 7.10M | 9.71M | 11.98M | 13.71M | 14.65M | 16.76M | 16.48M | 21.82M | 22.61M | 30.22M | 23.53M | ||||||||
| Net Income | |||||||||||||||||||
| Net Income | 36.69M
+0% |
47.02M
+28% |
53.82M
+14% |
67.46M
+25% |
76.82M
+14% |
91.66M
+19% |
105.14M
+15% |
135.12M
+29% |
172.23M
+27% |
209.25M
+21% |
226.67M
+8% |
||||||||
| Net Income Ratio | (0.05%) | (0.05%) | (0.06%) | (0.07%) | (0.07%) | (0.06%) | (0.06%) | (0.07%) | (0.08%) | (0.08%) | (0.12%) | ||||||||
| Earning Per Share | |||||||||||||||||||
| Basic EPS | 0.33 | 0.42 | 0.49 | 0.60 | 0.69 | 0.81 | 0.67 | 0.86 | 1.10 | 1.34 | 1.18 | ||||||||
| Diluted EPS | 0.33 | 0.42 | 0.49 | 0.60 | 0.69 | 0.81 | 0.67 | 0.86 | 1.10 | 1.34 | 1.18 | ||||||||
| Share Outstanding | |||||||||||||||||||
| Basic Share Outstanding | 110.72M | 111.93M | 110.93M | 111.77M | 111.92M | 113.07M | 156.56M | 156.56M | 156.56M | 156.56M | 191.56M | ||||||||
| Diluted Share Outstanding | 110.73M | 111.93M | 110.93M | 111.78M | 111.92M | 113.07M | 156.56M | 156.56M | 156.56M | 156.56M | 191.56M | ||||||||